OTTAWA—Although cannabis is increasingly suggested as a treatment for certain paediatric health conditions, evidence is lacking about the overall effect on children.
In a statement released today, the Canadian Paediatric Society (CPS) calls for careful evaluation of both the safety and efficacy of using cannabis to treat certain paediatric health conditions.
“Current considerations around cannabis use for medical purposes in children have been stimulated by recent case reports of its beneficial effect with refractory epilepsy,” says Dr. Michael Rieder, author of the new statement and chair of the CPS Drug Therapy and Hazardous Substances Committee. “However, there is little data to support either the efficacy or safety of cannabis use for any indications in children, and an increasing body of data suggests possible harm, most importantly in specific conditions.”
Other recommendations from the CPS include:
-30-
The Canadian Paediatric Society is a national advocacy association that promotes the health needs of children and youth. Founded in 1922, the CPS represents more than 3,300 paediatricians, paediatric subspecialists and other child health professionals across Canada.
Last updated: Dec 14, 2015